Therapeutics News
FDA advisers recommend approving weight loss drug
Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.Shares of the drug's creator, Arena Pharmaceuticals Inc., nearly doubled, jumping from $3.66 to $7.15 in after-hours trading after trading was temporarily halted.A panel of expert
Therapeutics Galleries
|
|
